| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
29,260,000 |
| Market
Cap: |
230.28(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.27 - $9.89 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile XBiotech is a biopharmaceutical company that discovers and develops True Human™ monoclonal antibodies for treating a variety of diseases. Co. has developed a pipeline of product candidates targeting both inflammatory and infectious diseases. An area of medical focus for Co. are therapies that block a substance naturally produced by body, known as interleukin-1 alpha, that mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting and inflammation. Co.'s product development includes: Natrunix program, which is for the indication of pancreatic cancer and rheumatoid arthritis, and Hutrukin program, which is for the indication of stroke.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mckenzie W Thorpe |
Director |
– • • |
2018-11-09 |
4 |
B |
$3.74 |
$8,217 |
I/I |
2,200 |
2,200 |
2.17 |
- |
|
| Mckenzie W Thorpe |
Director |
– • • |
2018-10-04 |
4 |
S |
$3.00 |
$1,155,000 |
D/D |
(385,000) |
3,398,600 |
|
- |
|
| Mckenzie W Thorpe |
Director |
– • • |
2018-09-26 |
4 |
S |
$3.05 |
$53,798 |
D/D |
(17,634) |
3,783,600 |
|
- |
|
| Mckenzie W Thorpe |
Director |
– • • |
2018-09-13 |
4 |
S |
$3.10 |
$24,549 |
D/D |
(7,909) |
3,801,234 |
|
- |
|
| Mckenzie W Thorpe |
Director |
– • • |
2018-09-12 |
4 |
S |
$3.06 |
$127,546 |
D/D |
(41,675) |
3,809,143 |
|
- |
|
| Mckenzie W Thorpe |
Director |
– • • |
2018-09-10 |
4 |
S |
$3.22 |
$75,335 |
D/D |
(23,369) |
3,850,818 |
|
- |
|
| Mckenzie W Thorpe |
Director |
– • • |
2018-09-07 |
4 |
S |
$3.65 |
$22,763 |
D/D |
(6,234) |
3,874,187 |
|
- |
|
| Mckenzie W Thorpe |
Director |
– • • |
2018-09-05 |
4 |
S |
$3.94 |
$28,481 |
D/D |
(7,220) |
3,887,580 |
|
- |
|
| Mckenzie W Thorpe |
Director |
– • • |
2018-09-04 |
4 |
S |
$3.99 |
$15,179 |
D/D |
(3,800) |
3,894,800 |
|
- |
|
| Mckenzie W Thorpe |
Director |
– • • |
2018-08-10 |
4 |
S |
$3.98 |
$12,623 |
I/I |
(3,171) |
0 |
|
- |
|
| Mckenzie W Thorpe |
Director |
– • • |
2018-08-09 |
4 |
S |
$4.00 |
$26,523 |
I/I |
(6,638) |
3,171 |
|
- |
|
| Mckenzie W Thorpe |
Director |
– • • |
2018-08-08 |
4 |
S |
$4.01 |
$16,024 |
I/I |
(4,000) |
121,309 |
|
- |
|
| Mckenzie W Thorpe |
Director |
– • • |
2018-08-07 |
4 |
S |
$3.94 |
$33,332 |
I/I |
(8,452) |
125,309 |
|
- |
|
| Mckenzie W Thorpe |
Director |
– • • |
2018-08-06 |
4 |
S |
$3.99 |
$13,328 |
I/I |
(3,340) |
133,761 |
|
- |
|
| Mckenzie W Thorpe |
Director |
– • • |
2018-08-03 |
4 |
S |
$3.96 |
$94,689 |
I/I |
(23,900) |
25,601 |
|
- |
|
| Mckenzie W Thorpe |
Director |
– • • |
2018-08-02 |
4 |
S |
$3.92 |
$119,529 |
I/I |
(30,461) |
49,501 |
|
- |
|
| Mckenzie W Thorpe |
Director |
– • • |
2018-08-01 |
4 |
S |
$4.24 |
$34,649 |
I/I |
(8,163) |
79,962 |
|
- |
|
| Mckenzie W Thorpe |
Director |
– • • |
2018-07-31 |
4 |
S |
$4.49 |
$29,320 |
I/I |
(6,531) |
88,125 |
|
- |
|
| Mckenzie W Thorpe |
Director |
– • • |
2018-07-30 |
4 |
S |
$4.41 |
$23,542 |
I/I |
(5,344) |
94,656 |
|
- |
|
| Han Queena |
VP Finance & HR |
• – – |
2018-03-23 |
4 |
S |
$4.75 |
$38,955 |
D/D |
(8,201) |
0 |
|
- |
|
| Han Queena |
VP Finance & HR |
• – – |
2018-03-23 |
4 |
OE |
$2.50 |
$20,503 |
D/D |
8,201 |
8,201 |
|
- |
|
| Han Queena |
VP Finance & HR |
• – – |
2018-03-22 |
4 |
S |
$4.76 |
$296,159 |
D/D |
(62,200) |
0 |
|
- |
|
| Han Queena |
VP Finance & HR |
• – – |
2018-03-22 |
4 |
OE |
$2.50 |
$155,500 |
D/D |
62,200 |
62,200 |
|
- |
|
| Han Queena |
VP Finance & HR |
• – – |
2018-03-21 |
4 |
S |
$4.48 |
$42,987 |
D/D |
(9,599) |
0 |
|
- |
|
| Han Queena |
VP Finance & HR |
• – – |
2018-03-21 |
4 |
OE |
$2.50 |
$23,998 |
D/D |
9,599 |
9,599 |
|
- |
|
124 Records found
|
|
Page 4 of 5 |
|
|
0.34 (4.14%) 
